Corrigendum to "Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation" [Toxicol. Appl. Pharmacol. 228 (2008) 105-113] (DOI:10.1016/j.taap.2007.11.027)

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Corrigendum to "Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation" [Toxicol. Appl. Pharmacol. 228 (2008) 105-113] (DOI:10.1016/j.taap.2007.11.027)'. Together they form a unique fingerprint.